657 related articles for article (PubMed ID: 32937917)
1. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease.
Kicman A; Toczek M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937917
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Durst R; Danenberg H; Gallily R; Mechoulam R; Meir K; Grad E; Beeri R; Pugatsch T; Tarsish E; Lotan C
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3602-7. PubMed ID: 17890433
[TBL] [Abstract][Full Text] [Related]
3. Is the cardiovascular system a therapeutic target for cannabidiol?
Stanley CP; Hind WH; O'Sullivan SE
Br J Clin Pharmacol; 2013 Feb; 75(2):313-22. PubMed ID: 22670794
[TBL] [Abstract][Full Text] [Related]
4. Safety and side effects of cannabidiol, a Cannabis sativa constituent.
Bergamaschi MM; Queiroz RH; Zuardi AW; Crippa JA
Curr Drug Saf; 2011 Sep; 6(4):237-49. PubMed ID: 22129319
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Adverse Effects and Toxicity.
Huestis MA; Solimini R; Pichini S; Pacifici R; Carlier J; Busardò FP
Curr Neuropharmacol; 2019; 17(10):974-989. PubMed ID: 31161980
[TBL] [Abstract][Full Text] [Related]
6. A Novel Standardized
Mabou Tagne A; Marino F; Legnaro M; Luini A; Pacchetti B; Cosentino M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013912
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
[TBL] [Abstract][Full Text] [Related]
10. Research progress in the management of vascular disease with cannabidiol: a review.
Guo Y; Wei R; Deng J; Guo W
J Cardiothorac Surg; 2024 Jan; 19(1):6. PubMed ID: 38172934
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases.
Naya NM; Kelly J; Hogwood A; Abbate A; Toldo S
Expert Opin Investig Drugs; 2024 May; ():. PubMed ID: 38703078
[TBL] [Abstract][Full Text] [Related]
12. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.
Bielawiec P; Harasim-Symbor E; Chabowski A
Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
14. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent.
Aebersold A; Duff M; Sloan L; Song ZH
Cell Physiol Biochem; 2021 May; 55(S5):1-14. PubMed ID: 33984199
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats.
Khaksar S; Bigdeli M; Samiee A; Shirazi-Zand Z
Brain Res Bull; 2022 Mar; 180():118-130. PubMed ID: 35031355
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol: State of the art and new challenges for therapeutic applications.
Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
[TBL] [Abstract][Full Text] [Related]
18. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Malfait AM; Gallily R; Sumariwalla PF; Malik AS; Andreakos E; Mechoulam R; Feldmann M
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9561-6. PubMed ID: 10920191
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.
Kogan NM; Melamed E; Wasserman E; Raphael B; Breuer A; Stok KS; Sondergaard R; Escudero AV; Baraghithy S; Attar-Namdar M; Friedlander-Barenboim S; Mathavan N; Isaksson H; Mechoulam R; Müller R; Bajayo A; Gabet Y; Bab I
J Bone Miner Res; 2015 Oct; 30(10):1905-13. PubMed ID: 25801536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
